160 related articles for article (PubMed ID: 38264609)
1. Evaluation of the effects of latanoprost and benzalkonium chloride on the cell viability and nonpolar lipid profile produced by human meibomian gland epithelial cells in culture.
Ziemanski JF; Wilson L; Barnes S; Nichols KK
Mol Vis; 2023; 29():289-305. PubMed ID: 38264609
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 and F2α Alter Expression of Select Cholesteryl Esters and Triacylglycerols Produced by Human Meibomian Gland Epithelial Cells.
Ziemanski JF; Wilson L; Barnes S; Nichols KK
Cornea; 2022 Jan; 41(1):95-105. PubMed ID: 34483274
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of benzalkonium chloride and prostaglandins on human meibomian gland epithelial cells.
Rath A; Eichhorn M; Träger K; Paulsen F; Hampel U
Ann Anat; 2019 Mar; 222():129-138. PubMed ID: 30580056
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
[TBL] [Abstract][Full Text] [Related]
5. Saturation of cholesteryl esters produced by human meibomian gland epithelial cells after treatment with rosiglitazone.
Ziemanski JF; Wilson L; Barnes S; Nichols KK
Ocul Surf; 2021 Apr; 20():39-47. PubMed ID: 33248214
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
[TBL] [Abstract][Full Text] [Related]
7. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
Ammar DA; Kahook MY
Mol Vis; 2011; 17():1806-13. PubMed ID: 21750606
[TBL] [Abstract][Full Text] [Related]
8. The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells.
Nagstrup AH
Acta Ophthalmol; 2023 Dec; 101 Suppl 278():3-21. PubMed ID: 38037546
[TBL] [Abstract][Full Text] [Related]
9. Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells.
Hedengran A; Freiberg J; May Hansen P; Boix-Lemonche G; Utheim TP; Dartt DA; Petrovski G; Heegaard S; Kolko M
J Optom; 2024; 17(1):100481. PubMed ID: 37788596
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Cell Harvesting Techniques to Optimize Lipidomic Analysis from Human Meibomian Gland Epithelial Cells in Culture.
Ziemanski JF; Chen J; Nichols KK
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384602
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
Baudouin C; Riancho L; Warnet JM; Brignole F
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4123-8. PubMed ID: 17724196
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system.
Yee RW; Norcom EG; Zhao XC
Adv Ther; 2006; 23(4):511-9. PubMed ID: 17050493
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation.
Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Pharmacology of Latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles.
Halder A; Khopade AJ
Curr Eye Res; 2021 Jul; 46(7):1031-1037. PubMed ID: 33719796
[No Abstract] [Full Text] [Related]
15. Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system.
Ryan G; Fain JM; Lovelace C; Gelotte KM
BMC Ophthalmol; 2011 Apr; 11():8. PubMed ID: 21510881
[TBL] [Abstract][Full Text] [Related]
16. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
Whitson JT; Petroll WM
Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
[TBL] [Abstract][Full Text] [Related]
17. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985
[TBL] [Abstract][Full Text] [Related]
18. Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients.
Kestelyn PA; Kestelyn PG; De Bacquer D; Stevens AM
Int Ophthalmol; 2019 Jan; 39(1):105-109. PubMed ID: 29274019
[TBL] [Abstract][Full Text] [Related]
19. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
20. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
